Symbol
CTSO on Nasdaq
Investment type
Equity / Common Stock
Latest Disclosed Shares Owned
3,755,273 shares
Security Ownership %
5.7%

Avenue Capital Management II, L.P. ownership in Cytosorbents Corp Common Stock (CTSO)

28 May 2025 - Avenue Capital Management II, L.P. has filed an SCHEDULE 13G form with the Securities and Exchange Commission (SEC) disclosing ownership of 3,755,273 shares of Cytosorbents Corp Common Stock (CTSO). This represents 5.7% ownership of the company. This is the first filing by Avenue Venture Opportunities Fund, L.P. disclosing ownership of Cytosorbents Corp Common Stock (CTSO).